Other News To Note
• Kymab Ltd., of Cambridge, UK, said it notified the English Court that it will defend the UK patent proceedings brought by Tarrytown, N.Y.-based Regeneron Pharmaceuticals Inc. in respect of European patent EP1360287. Regeneron initiated the proceedings in September. Kymab said it will defend the UK patent action on the grounds of non-infringement and invalidity of the patent.
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST